Can Abilify (aripiprazole) be taken with Paxil (paroxetine)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 9, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can Abilify Be Taken With Paxil?

Yes, Abilify (aripiprazole) can be safely taken with Paxil (paroxetine), and this combination is specifically studied and used in clinical practice for treatment-resistant depression. 1, 2

Evidence for Combined Use

The combination of aripiprazole with paroxetine has been directly evaluated in clinical trials and shown to be both effective and well-tolerated:

  • A head-to-head comparison study demonstrated that paroxetine augmented with aripiprazole was equally effective and well-tolerated in patients with refractory major depressive disorder. 1

  • A large double-blind, placebo-controlled trial (N=1,147) specifically included paroxetine controlled-release as one of the antidepressants used with aripiprazole augmentation, showing clinically significant improvements in depressive symptoms with low discontinuation rates due to adverse events (6.2%). 2

  • The combination achieved a two-fold higher remission rate (36.8%) compared to antidepressant monotherapy with placebo (18.9%), with high completion rates (83%). 2

Clinical Context for Use

This combination is primarily indicated when:

  • Patients with major depressive disorder show inadequate response to paroxetine monotherapy after an adequate trial. 1, 2

  • Aripiprazole is added as augmentation therapy, typically starting at 2-5 mg/day and titrating up to 20 mg/day as needed. 2

Safety Considerations

Monitor for serotonin syndrome risk, though this combination has been well-studied: While paroxetine is a serotonergic agent (SSRI), aripiprazole's unique mechanism as a partial dopamine agonist rather than a pure serotonergic agent makes this combination relatively safe. 3, 4

Watch for extrapyramidal symptoms (EPS): Aripiprazole can cause EPS, particularly with long-term use, though it has a lower risk profile compared to other antipsychotics. 5, 6

Consider metabolic monitoring: The aripiprazole-SSRI combination presents a lower risk of metabolic side effects compared to other antipsychotic combinations, but baseline and periodic monitoring of weight, glucose, and lipids is prudent. 6

Be aware of weight effects: Paroxetine is associated with weight gain among SSRIs, and aripiprazole can also cause weight gain, particularly in younger patients. 7, 5

Practical Implementation

  • Start aripiprazole at low doses (2-5 mg/day) and titrate slowly while maintaining the established paroxetine dose. 2

  • Assess response within 4-6 weeks of adding aripiprazole, looking for improvements in depressive symptoms using standardized scales. 1, 2

  • Common side effects of the combination include sedation, akathisia, and gastrointestinal symptoms, but discontinuation rates due to adverse events remain low. 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.